NHS Wales Approves Biogen’s Plegridy for Relapsing Remitting MS

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis

Relapsing
remitting multiple sclerosis (RRMS) treatment Plegridy (peg interferon
beta-1a) by Biogen Idec, has just received Welsh NHS approval, which should
make it available to patients by late October 2015. The decision follows
NHS Scotland’s approval earlier this year, however, the biweekly interferon
beta shot has yet to be made available in England’s NICE healthcare
system. Plegridy was approved across […]


Read on »

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT with MS Views and News – OPT-IN here
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews